Systemic anti-cancer therapy delivery in the home: a service model
Affiliation
SACT Outreach Manager, The Christie NHS Foundation Trust, Manchester.Issue Date
2020
Metadata
Show full item recordAbstract
The Christie NHS Foundation Trust is a leader in adapting patient care in response to treatment advances and new patient-centred care/efficiency initiatives. Due to extended waiting times in cancer clinics, The Christie developed an at-home treatment service to help reduce the pressure on clinics and improve patient experience. This article provides a detailed examination of the requirements necessary to successfully develop a home service for the delivery of systemic anticancer treatment. The authors discuss the criteria used to identify suitable at-home treatments, as well as necessary resources and equipment. The success of the Christie at Home service was examined using a patient survey to assess the standard of this care. Details are given regarding the challenges of implementing a homecare service and potential future challenges. As an example, systemic treatment with eribulin as a 'Christie at Home' therapy demonstrates the practicalities of introduction of new therapies in a homecare service.Citation
V. Burns, V. Misra and N. Paton. Systemic anti-cancer therapy delivery in the home: a service model. Br J Nurs. 2020;29(10):S22-S29.Journal
British Journal of NursingDOI
10.12968/bjon.2020.29.10.S22PubMed ID
32463747Additional Links
https://dx.doi.org/10.12968/bjon.2020.29.10.S22Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.12968/bjon.2020.29.10.S22